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INTRODUCTION
The selective ablation of specific cell types in
transgenic mice through the expression of
toxin genes is a useful approach in cell lineage
experiments in vivo (1–4). By means of the
glucagon promoter-driven expression of a diph-
theria toxin (DT) A gene, we demonstrated that
glucagon cells are not precursors of insulin-
producing cells (3). We pursued these analyses
by labeling progenitor cells through the expres-
sion of Cre recombinase in doubly transgenic
mice (5). With this approach, we, and subse-
quently others, have been able to show that all
pancreatic cells differentiate from pdx1-
expressing precursors (unpublished observa-
tions and (5–7)). Similarly, p48 activity is found
in precursors of both exocrine and endocrine
pancreatic cell lineages (8). We have also
shown that islet endocrine cells derive from
progenitor cells that express ngn3 and pax6
genes almost concomitantly (unpublished
observations and (7)), and that insulin cells do
not derive from glucagon-expressing progeni-
tors, nor glucagon cells from insulin progeni-
tors (5). 
PANCREAS DEVELOPMENT
The pancreas is a mixed gland. The exocrine
pancreas represents the majority of the tissular
mass and is composed of secretory acini and
excretory ducts. Clusters of cells, the islets of
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Langerhans, are embedded in the exocrine tis-
sue and form the endocrine pancreas. Islets are
composed of four cell types: β-cells that pro-
duce insulin, and α-, σ-, and PP cells that pro-
duce glucagon, somatostatin, and pancreatic
polypeptide, respectively. 
Organogenesis From Several 
Pancreatic Buds 
The pancreas initially develops from distinct
dorsal and ventral primordia brought together
to form the single mature organ. This involves a
cascade of inductions associated with the
expression of particular transcription factors.
Pancreatic buds evaginate from the early
foregut endoderm caudal to the stomach pri-
mordium, near the prospective liver; the mole-
cular determinants that define the position of
the pancreas along the anterior–posterior axis
remain unknown (9,10). The first hormone-con-
taining cells found in early primordia appear
located exclusively within the epithelia of the
embryonic ducts or cords (11,12). Because these
cells often simultaneously express more than
one hormone (12–14), the existence of a com-
mon, glucagon-expressing precursor cell for all
four islet cell types was proposed (15). 
Commitment to a pancreatic fate occurs as
early as embryonic d 8–8.5 (E8–E8.5) in mice.
Permissive signals released from adjacent
mesodermal structures, including the noto-
chord, aorta, and cardiac mesoderm, are
important for induction of the pancreatic pro-
gram. The notochord induces dorsal pancreas
development through the inhibition of Shh
(Sonic hedgehog) expression in prepancreatic
dorsal endoderm. Shh is expressed in the early
gut endoderm and aids in its development
(9,16–18). This Shh repression, which appears
to be mediated by activin βB and Fibroblast
growth factor-2 (FGF2) (19), is permissive for
the expression of Pdx1. Shh is also repressed,
and Pdx1 expressed, in the ventral prepancre-
atic endoderm. 
It is intriguing that the same mesenchymal
morphogens have opposite inductive effects on
the dorsal and ventral pancreas; in the absence
of dorsal mesoderm, the dorsal endoderm
expresses liver markers, whereas without ven-
tral mesoderm (i.e., without cardiac mesoderm
and septum transversum), the ventral endo-
derm “defaults” to pancreas formation instead
of liver. Indeed, signals from ventral mesoderm
(FGFs) promote hepatic development (20). 
The first indication of morphogenesis occurs
at E9.5, when the dorsal mesenchyme con-
denses and the underlying endoderm evagi-
nates to form a recognizable dorsal pancreatic
bud; the ventral bud appears 1 d later (E10.5).
Both buds, stimulated by mesenchymal sig-
nals, subsequently proliferate and form multi-
ple branches, which ultimately fuse together
by day E14 (the ventral bud translocates
toward the dorsal during gut rotation). 
Timing of Appearance of Differentiated
Endocrine Phenotypes 
In mice, the first identifiable differentiated
cells are glucagon-producing cells. These cells
are detectable already at E9.5 in the dorsal pan-
creatic bud and 1 d later in the ventral, whereas
the first insulin-producing cells are present the
following day (E10.5–E11) in both primordia.
After branching, at E13.5, somatostatin-posi-
tive cells are detectable in both buds, and the
exocrine pancreas containing well-formed
acini begins to differentiate at E14.5. Three
days before birth, at E16.5, PP-secreting cells
are also detected (unpublished observations)
and the first islets of Langerhans are formed at
E18.5 (12).
We determined the timing of hormone gene
expression by reverse transcriptase-poly-
merase chain reactions of total RNAs extracted
from pancreatic buds and surrounding tissues
at different developmental stages (12,21).
Glucagon and somatostatin mRNAs are found
very early (E8.5–E9), probably from extrapan-
creatic sources; insulin I transcript was
detected in E10.5 buds, whereas insulin II was
found only 1 d later. Surprisingly, PP mRNA is
detected from E10.5 onward, thus indicating
PP gene expression early in the developing
mouse pancreas. 
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Islet Formation 
Analysis of endocrine cells in situ suggests
three major patterns of endocrine cell localiza-
tion in embryonic pancreas. The earliest hor-
mone-containing cells are individual cells
located within the epithelium of pancreatic
ducts. In both dorsal and ventral buds, the
majority of these endocrine cells contain more
than one hormone costored within the same
secretory granules (12). Subsequently, these
cells migrate into the surrounding interstitia,
forming clusters of irregular shape and size that
become vascularized quickly. This process
involves interactions between cells through
adhesion molecules and active proteolysis of
the extracellular matrix (9,22). For instance, col-
lagen IV, which is a component of basement
membranes, is absent at the places where these
first endocrine cells appear (Fig. 1; unpublished
observations). Finally, starting on E18.5, as indi-
cated previously, typical islets are formed with
centrally located β-cells and with the adult “one
cell-one hormone” phenotype (12).
TRACKING CELL FATES IN THE
PANCREAS: HISTORICAL SYNOPSIS
Development of metazoan organisms from
one-celled embryos requires that cells pro-
gressively become highly specialized to fulfill
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Fig. 1. Immunohistochemical analysis of pancreatic buds cultured in collagen gels. Two consec-
utive semithin sections of an E12.5 pancreatic bud cultured for 7 d were stained with two different
antibodies: antiglucagon (A) and anticollagen IV (B). Clusters of endocrine cells stained with
antiglucagon antibody (A) migrate from the ductlike cords of epithelial cells into the surrounding
mesenchyme. This process involves interactions between endocrine cells and the extracellular
matrix (ECM), through adhesion molecules, and active proteolysis of the ECM, as illustrated with
the anticollagen IV staining (B). Collagen IV is a main component of epithelial basement mem-
branes. Digestion of collagen IV is shown to occur at places were endocrine clusters of cells are bud-
ding (asterisks in panel (B)). Scale bar is 20 µm. 
particular tasks; interactions between neigh-
bor cells determine their respective destiny.
Understanding these developmental processes
implies knowledge of the precise lineages of
cells, and the observer requires a method to
reliably identify particular cells and all of their
progeny to reveal their fates. 
To follow cells over long periods and
through complex differentiation programs,
irreversible (genetic) tagging is required. Three
different cell-lineage tracing techniques are
summarized in Table 1.
Generation of Mosaics
Embryos can be marked through infection
with replication-deficient retroviruses bearing
a gene encoding a marker (such as β-galactosi-
dase, alkaline phosphatase, or green fluores-
cent protein [GFP]) (23–26). The approach
consists in using a low viral titer so that infec-
tion is a rare event; therefore, marked cells in a
given infected embryo are assumed to be clon-
ally related. Infected embryos are thus mosaics
of marked and unmarked cells. The main dis-
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Table 1
Overview of the Methods Used to Trace Cell Lineages
Approach Limitations
Tracer marking Vital dyes (73,74) Groups of cells The marker dilutes 
are labeled as cells divide
Radiolabeled nucleotides (75) Diffusible between 
adjacent cells
Carbocyanine dyes (Dil; DiO) —
Intracellular tracers (enzymes, Microinjection is 
fluorochrome-labeled dextrans) technically difficult
Gold-labeled antibodies (76) —
Genetic marking Mosaicism “Retrograde” analysis
(irreversible Retroviruses Uncertainty
tagging) Chimerism —
In vitro grafting
In vivo grafting
(interspecies chimera)
Embryo aggregation/
ES cells injection
Transgenesis
(Reporter) (trans-) gene Genes are expressed transiently
expression
Targeted oncogenesis Tumor cell lines are profoundly abnormal
Gene targeting (KO and Cell autonomous vs noncell autonomous 
KI mice) gene activity
Random transgene modification Mosaicism (retrograde analysis)
(activation or inactivation)
Targeted cell ablation (toxigene) Vertical vs horizontal relationships
Targeted genetic cell labeling —
(Cre/LoxP system)
advantage of this approach, apart from the
uncertainty regarding the interpretation of the
results, is that labeled cells are not chosen
directly; this lineage analysis is thus “retro-
spective.” Using this method with pancreatic
rudiments cultured in vitro, Fishman and
Melton demonstrated that a single infected
pancreatic progenitor cell is able to give rise to
both exocrine and endocrine cells (25).
Generation of Chimeras
Another way to circumvent the problem of
dilution of tracer dyes was devised in the
1920s through the generation of interspecies
chimeras by transplantation (grafting) or, much
later, by aggregating two mouse embryos.
Chimeras are derived from more than one
embryo; therefore, their bodies are formed of
cells from different individuals having differ-
ent genetic constitutions. In transplantation
chimeras, donor and host cells can be easily
distinguished by morphological differences
(27–31). With this method (grafting quail neural
crest cells on chick embryos), Le Douarin
demonstrated that neural crest cells do not
contribute to the formation of pancreatic
endocrine cells (30). 
In vitro grafting (i.e., tissue cocultures of
rudiments from different embryos) is another
variation of the chimera approach. With this
system, Percival and Slack (32) showed that the
pancreatic mesenchyme does not contribute to
pancreatic cells; when labeled prepancreatic
endoderm was cultured with unmarked mes-
enchyme, only the endoderm gave rise to acini,
ducts, and islets. 
Mouse aggregation chimaeras, using, for
instance, transgenic and wild-type morulae, or
chimeras generated by injection of pluripotent
ES cells into host blastocysts, are powerful
tools to identify different cell populations
within a single organ in vivo. With the embryo
aggregation approach, Jami and coworkers
demonstrated that pancreatic islets of
Langerhans are of polyclonal origin (i.e., that
endocrine cells within a particular islet derive
from different progenitors) (33). 
Generation of Transgenics
Two sophisticated methods, using trans-
genic mice, have been introduced more
recently, and both were first employed by our
laboratory to trace pancreatic cell lineages (3,5).
The first is based on targeted ablations of given
cell types by means of cell type-specific pro-
moters to express toxin genes. The rationale is
that missing cells are derived from, or depen-
dent on, the cell type destroyed, which would
then be a putative precursor or adjuvant cell. A
refinement of this approach was successfully
used to address the enteroendocrine cell lin-
eages through the conditional ablation of
secretin cells, on administration of ganciclovir,
in transgenic mice expressing herpes simplex
virus 1 thymidine kinase under the control of a
secretin promoter (4). The viral enzyme herpes
simplex virus 1 thymidine kinase phosphory-
lates the thymidine analog ganciclovir, which
renders it mutagenic and cytotoxic. 
The second approach is the irreversible tar-
geted tagging (labeling) of a given cell type
using a promoter to express Cre recombinase
(Cre/LoxP system) (34,35). This is the most
reliable and powerful method to trace cell lin-
eages in Amniota in vivo; it permits detection
of descendants that no longer express the gene
of interest (Fig. 2). 
Both approaches were pioneered in pancre-
atic rudiment cell lineage tracing, and are dis-
cussed in more detail in the following sections
(3,5). I now summarize some knockout experi-
ments that have demonstrated a crucial role for
a few genes in pancreas development. 
CELL VS NONCELL AUTONOMOUS
EXPRESSION OF GENES
Inactivation of genes (gene targeting or abla-
tion) in knockout (KO) mice is one way to study
their function. This may result in loss of some
particular cell type(s) or activation of reporter
gene expression (knock-in mice). Although
these results have been considered by some
workers as a means to identify precursor cells,
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this is conceptually wrong. Genes are often
expressed transiently, and cytodifferentiation
during development is based on differential
gene expression. Moreover, many genes act
non-cell autonomously (i.e., in paracrine ways).
As a consequence, cell ablation resulting from
null mutations (KO mice) cannot be taken as
evidence of cell lineage relationships among
different cell types. Strictly, the gene KO exper-
iments tell us whether a given gene is necessary
for a given cell type to differentiate. 
Mesenchymal factors are non-cell auto-
nomous inducers of epithelial (endodermal)
cell differentiation. Epithelial-mesenchymal
interactions are essential for pancreas morpho-
genesis and cytodifferentiation. Different pan-
creatic lineages require different mesenchymal
factors for their development. For instance,
when the pancreatic bud epithelium is cultured
in the absence of mesenchyme, or grafted
under the renal capsule, only endocrine cells
differentiate (36). The identity of most soluble
mesenchymal factors remains unclear, but the
transforming growth factor (TGF)-β, FGF, and
epidermal growth factor (EGF) signaling path-
ways appear to be involved (9,16,37). The TGF-
β superfamily accessory binding protein
follistatin, which is expressed in pancreatic
mesenchyme, promotes exocrine differentia-
tion (22), whereas treatment with TGF-β1 has
the opposite effect (38–41). 
Targeted disruption of Isl1 (ISLET1, a LIM
homeodomain protein), which is expressed in
early endocrine cells, abolishes endocrine dif-
ferentiation (Table 2). Isl1 is nevertheless first
expressed in the mesenchyme surrounding the
dorsal primordium. In Isl1-/- embryos there is
no dorsal pancreatic bud, and this is a conse-
quence of the lack of dorsal mesenchyme (42). 
Inactivation of the adhesion molecule N-cad-
herin also results in agenesis of the dorsal pan-
creas, which is associated again with a loss of
dorsal mesenchyme (43). Interestingly, in these
animals the Isl1 expression persists in the mes-
enchyme and in prospective dorsal pancreatic
epithelium, whereas dorsal Pdx-1 expression is
normal by E9 but is then rapidly restricted to
the prospective ventral pancreas. Because Pdx-1
is similarly dorsally downregulated in Isl1-/-
mice (42), it appears that the dorsal mes-
enchyme is necessary to maintain Pdx-1
expression. In vitro recombination experiments
demonstrate that wild-type mesenchyme res-
cues morphogenesis and cytodifferentiation in
N-cadherin-/- dorsal endoderm. 
Transcription Factors 
in Pancreas Development
Even though transcription factors are likely
to act cell autonomously, the consequences of
their activity indirectly affect neighbor cells in
a paracrine (non-cell autonomous) way. Many
transcription factors, mostly homeobox genes,
have been mapped to specific regions of the
endoderm, and to the surrounding visceral
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Fig. 2. Tracing cell lineages with the Cre/LoxP strategy. (A) To genetically label pancreatic prog-
enitor cells, two different strains of transgenic mice are needed. The “reporter mouse” bears a
reporter transgene (in the cartoon the β-galactosidase coding region) placed under the control of a
promoter (either tissue-specific or ubiquitous) and downstream of a LoxP-flanked transcription ter-
mination cassette (STOP sequence). The “tagger” mouse (“marker” or “deletor” mouse) has a trans-
gene encoding the Cre recombinase gene under the control of a cell-specific promoter, such as
would be active in putative pancreatic progenitor cells. In doubly transgenic mice, the expression
of the tagger transgene in a precursor cell results in the excision of the reporter’s STOP sequence,
thus allowing its expression (β-galactosidase). This tag is then genetically transmitted to all the
progeny of this cell and permits the tracing of its lineage during the formation of the pancreas. In
(B), the transgenes described in the text are shown.
mesenchyme, and are likely to modulate the
mesoderm-endoderm interactions (44). Their
involvement in pancreas determination,
growth, and differentiation, has been assessed
by their selective inactivation in mice (summa-
rized in Table 2). Factors more relevant to pan-
creas development are briefly discussed herein. 
PDX1 (pancreatic and duodenal homeobox-
1) is, together with the homeodomain protein
HB9, the earliest marker of pancreatic bud cells,
from E8.5. PDX1 is necessary for the develop-
ment of the pancreas, because Pdx1-deficient
mice have pancreatic aplasia (45,46). However,
insulin and glucagon cells are present in early
embryonic buds of Pdx1-/- mice, and their pan-
creatic mesenchyme develops normally. Pdx1 is
not a “master control gene,” because its ectopic
expression in the hindgut endoderm is not suf-
ficient to trigger pancreas formation (47). 
The inactivation of two bHLH transcription
factors, PTF1-p48 and Ngn3, suggest that they
could be implicated in determining whether an
early pancreas cell is to become exocrine or
endocrine. Mice in which PTF1-p48 is inacti-
vated have no exocrine pancreas (8,48),
whereas inactivation of Ngn3 results in agene-
sis of endocrine pancreas (49). In pancreatic
buds, NGN3 is detected in proliferating cells
expressing PDX1, but not in hormone-contain-
ing cells. Overexpression of Ngn3 (under the
control of a Pdx1 promoter, in transgenic
mouse embryos, or of a ubiquitous promoter,
in electroporated chick embryos) is sufficient to
drive differentiation of glucagon cells, but not
of insulin cells (44,50,51). 
In the absence of the paired-box domain pro-
tein PAX6, known to be downstream of ISL1,
and initially expressed in all pancreatic
endocrine cells, the development of all
endocrine lineages is affected (52). The PAX4
protein is specifically necessary for the produc-
tion of mature β and σ cells (53). Interestingly,
in Pax6-/- and Pax4-/- double mutants, islets
are totally absent. 
In summary, the gene inactivation studies
show, among many other interesting findings,
that (1) several mesenchymal factors, whether
soluble factors, adhesion molecules, or tran-
scription factors, are needed for pancreas
development—by activating genes in the
prospective pancreatic endoderm; (2) Pdx1 is
necessary for growth of both pancreatic rudi-
ments; (3) ptf1-p48 activity is required for
exocrine pancreas differentiation; and (4) Ngn3,
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Table 2
Some Factors Involved in Pancreas Development, as Determined Using KO Mice
Targeted Gene Dorsal Pancreas Ventral Pancreas Ref.
Pdx1 Aplasia (45,46,67)
Ngn3 No islets (49)
PTF1-p48 No exocrine celss (48)
Pax4 No β- nor δ-cells (53)
Pax6 No α-cells; Endocrine hypoplasia (52)
Isl1 Agenesis; no mesenchyme No endocrine cells (42)
Hlxb9 Agenesis Fewer β-cells (68;69)
Hes1 Hypoplasia (54)
N-cadherin Agenesis; no mesenchyme Normal (43)
Beta2/NeuroD Fewer β-cells; distorted islets (70)
Hnf6 Endocrine hypoplasia (71)
Pbx1 Hypoplasia (16)
Nkx2.2 Immature β-cells (72)
as well as Pax6 and Pax4, are necessary for the
differentiation of islet endocrine cells. 
Together, these results suggest that some
gene products (ISL1, N-Cadherin, PDX1, p48,
and NGN3), whose inactivation induces loss of
differentiated cells, are candidate markers for
pancreatic progenitor cells. The KO experi-
ments also point to the principal role of the
mesenchyme, whose absence inhibits pancreas
formation, even though it has been reported
not to directly contribute cells to the pancreas
(32). This clearly illustrates that, even though
extremely important, gene inactivation experi-
ments cannot be interpreted as indicative of
cell lineages when they result in cell loss.
Therefore, we decided to genetically mark the
cells expressing these candidate genes in trans-
genic mice to determine whether they give rise
to the different adult pancreatic cell types. 
TRACING PANCREATIC CELL
LINEAGES BY DELETING OR
MARKING SPECIFIC CELL TYPES 
IN TRANSGENIC MICE
Ablation of Islet Cells by Targeted
Expression of Hormone Promoter-Driven
Toxigenes
Until the Cre/LoxP system was developed in
the mid-1990s, targeted cell ablation through
the expression of toxin genes was the best
approach to study the ontogenetic, or cell lin-
eage, relationships between the different types
of endocrine cells in islets. In a transient trans-
genic study, we generated embryos in which
cells transcribing glucagon, insulin, or PP genes
were destroyed by the promoter-targeted
expression of DT A (3). If, as proposed by oth-
ers, insulin cells were the descendants of
glucagon-producing precursors, then the abla-
tion of all glucagon-expressing cells would pre-
clude the differentiation of insulin cells. On the
contrary, we unambiguously demonstrated that
glucagon expressing cells are not essential for
the differentiation of β-cells, nor are insulin
gene expressing cells essential for α cells. These
experiments also indicated a close ontogenetic
relationship between insulin, PP, and somato-
statin cells, because DT A expression using a rat
PP promoter resulted in concomitant loss of PP,
insulin, and somatostatin cells. Whether this
requirement of PP-expressing cells is through a
cell lineage relationship or because such cells
produce paracrine or endocrine factors neces-
sary for the differentiation of insulin and
somatostatin cells from undefined precursors
remained undetermined with this approach. 
Islet Cell Lineage Analyses by Irreversibly
Labeling Cell Progenitors
Recent developments in gene recombination
technology have allowed the irreversible
“marking” of cells at one developmental stage
using the promoter of a given active candidate
marker gene, and therefore permit identifica-
tion of all their descendants when the pro-
moter is no longer active (Fig. 2).
In the context of our work, cells were genet-
ically labeled that transcribe Pdx1, Ngn3, Pax6,
glucagon, insulin, or PP genes early during
development, and the analysis of islet α and β-
cells, or the total pancreas, later in develop-
ment or in the adult, to determine whether
they are derived from these early Pdx1, Ngn3,
Pax6, glucagon, insulin, or PP gene-expressing
cells (5) (Fig. 3). To study the cell lineages of the
endocrine pancreas we used a silent LoxP-
bearing reporter transgene that is "activated" in
a tissue-specific manner through the activity of
Cre recombinase made from a second tagger
transgene (54).
The experimental design requires the gener-
ation of mice bearing two transgenes (summa-
rized in Fig. 2). One transgene, the “reporter,”
is placed under the control of either tissue-spe-
cific (5) or ubiquitous promoters (6–8,55–57)
and contains the human growth hormone (5),
β-galactosidase (58), human alkaline phos-
phatase (6,56), or enhanced GFP (EGFP) (57)
coding region placed downstream of a
“floxed” (i.e., loxP-flanked) transcription ter-
mination site (STOP sequence) (59–61).
Expression of the native reporter transgene
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requires the deletion of this sequence, which is
obtained in the presence of Cre recombinase. 
The second transgene, the “tagger,” con-
sists of the Cre recombinase gene placed
under the control of a promoter (transgenic or
endogenous, as in knock-in mice) active in
putative progenitor cells. Cre expression
results in the irreversible deletion of the STOP
(blocking) sequence of the reporter transgene,
which is, in turn, activated, and thus labels all
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progeny derived from those progenitors that
originally expressed the tagger. Others have
used this approach to analyze the life span of
circulating memory T cells (59), but not to
trace cell lineages.
Using lineage-specific expression of Cre
recombinase, we first showed that islet α- and
β-cell lineages appear to arise independently
during ontogeny from a common Pdx1-express-
ing precursor (5) (Fig. 3A,B; Fig. 4). The cell
ablation results (3) were thus confirmed and, in
addition, it was discovered that the insulin cell
lineage express the PP gene transiently (i.e., that
insulin cells derive from PP+ progenitors) and
that glucagon cells, which do not express Pdx1,
actually descend from PDX1+ progenitors. This
observation, combined with the fact that
glucagon cells are present in early pancreatic
buds in Pdx1-/- embryos, is illustrative of the
different nature of early (embryonic) and
mature (islet) glucagon cells. 
A newly available ubiquitous reporter
mouse, R26R, made it possible to analyze all
pancreatic cell lineages (6,7,55). These studies
confirmed that Pdx1 is expressed, at least
transiently, in all pancreatic cell types (6,7)
(Fig. 3A,B), and that all islet endocrine cells
derive from progenitors having transiently
expressed Ngn3 (7) (Fig. 3C,D; Fig. 4). 
The Cre-loxP system was initially devised to
inactivate genes in selected tissues, rather than
in the whole organism (34,35). A subsequent
refinement of this system allowed the exquisite
temporal control of the recombinant activity of
Cre in selected cells. One of these approaches
consists of a fusion enzyme, Cre-ERT, in which
the ligand-binding domain of a mutated estro-
gen receptor (ERT) that recognizes the antiestro-
gen tamoxifen (hydroxytamoxifen, 4-OHT), has
been fused to Cre. In the absence of 4-OHT, Cre-
ERT remains in the cytoplasm. Administration
of 4-OHT results in its migration into the
nucleus, as expected for a steroid hormone
receptor–ligand complex. Accordingly, Cre-
mediated recombination of genomic DNA is 4-
OHT-dependent in mice bearing a Cre-ERT
transgene (62,63). Because 4-OHT is active for
less than 48 h in mouse embryos, Gu and
coworkers were able to pulse labeling Ngn3- or
Pdx1-expressing cells during 1–2-d windows of
development by using Ngn3-CreERT and Pdx1-
CreERT transgenes. The results with the latter
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Fig. 3. Pancreatic cell lineage analyses. To study the cell lineages of pancreatic cells, we used, as
reporter mice, strain R26R (55), and five different transgenic mice as taggers: (A, B) Pdx1-cre (5,6),
(C, D) Ngn3-cre (P.L.H., unpublished results), (E, F) Pax6-cre (66), (G, H) glucagon-cre (5), and (I, J)
insulin-cre (5), among others. PDX1 is an early marker of pancreatic bud cells (E8.5) and is also
found in the duodenal wall. In Pdx1-cre/R26R doubly transgenic embryos(A, B), β-galactosidase
staining is found from E9.5 in the dorsal and ventral pancreatic buds and in the future duodenum
(A) (an E11.5 embryo is shown). In adults, the entire pancreas and many duodenal cells are stained
(B). These results demonstrate that Pdx1+ cells and their progeny participate in the formation of
these two organs, and are pancreatic progenitor cells. NGN3 and PAX6 are shown to be essential
for islet morphogenesis (Table 1), and are expressed early (from E9.5) in pancreatic development. In
Ngn3-cre/R26R (C, D) and Pax6-cre/R26R (E, F) mice, β-galactosidase activity is shown in dorsal
pancreatic buds—(C), E10.5, and (E), E11.5—and in all endocrine cells forming the adult islets (D,
F), demonstrating that NGN3+ and PAX6+ cells are endocrine progenitor cells. In glucagon-
cre/R26R (G, H) and insulin-cre/R26R (I, J) mice, β-galactosidase staining is found in pancreatic
buds at E11.5 and earlier (G, I) (E11.5 embryos are shown), and in α cells (H) and β-cells (J) in
mature islets, respectively. (Note in panel (H) that only peripheral islet α cells are blue). All these
results illustrate the power of the Cre/LoxP strategy to study cell lineages. d, duodenum; db, dor-
sal bud; s, stomach; vb, ventral bud. Scale bars are 0.25 mm in (A), (C), (E), (G), (H), and (I); 1 mm
in (B), (D), (F), and (J).
transgene were unexpected, for early labeling
(at E8.5) marked only acinar and islet cells, but
not ducts; indeed, duct cells were labeled only
when 4-OHT was administered between E9.5
and E11.5. At E12.5, or later, only acini and islets
were marked. This indicates that adult ducts
develop from precursors expressing Pdx1
before E12.5 but after E8.5. In accordance with
this interpretation, another elegant study in
which pancreas development is modulated
with doxycycline through activation or inacti-
vation of Pdx1 activity, also points to a Pdx1-
independent ductal development after this
E12.5 stage (64). The presence of rare NGN3+
cells in the adult islet was also demonstrated in
Ngn3-CreERT transgenics. Such cell population
might contribute to the maintenance of the
adult islet mass (7). 
Ptf1-p48 inactivation suggested that this gene
is required for exocrine pancreas development
(48). To trace the lineage of Ptf1-p48-expressing
cells, Kawaguchi et al. (8) placed the Cre recom-
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Fig. 4. Schematic representation of endodermal cell lineages as deduced from the Cre/LoxP-
mediated irreversible labeling of precursor cells. Liver, pancreas, and intestine derive from the same
embryonic layer, the endoderm. Several reports show that Pdx1 and p48 transcription factors are
expressed in early presumptive pancreatic endodermal cells that are the progenitors of the entire
pancreas (6–8). p48 has been reported to be restricted later to the exocrine progenitor cells. Ngn3,
which is expressed from E9.5 in early ducts or cords, is expressed in the progenitors of endocrine
cells (7) (present report, Fig. 3C,D). Pax6, another transcription factor acting downstream of Pdx1,
p48, and Ngn3, has also been shown to be expressed in endocrine progenitor cells (66) (present
report, Fig. 3E,F). That glucagon-producing α cells represent an independent lineage was shown in
two different reports (3,5) (present report, Fig. 3H, in which a glucagon-Cre transgene labels only α
cells). Insulin-containing β-cells derive from PP-expressing progenitors, which are also required for
the differentiation of somatostatin-containing σ-cells (3), either directly or noncell autonomously.
binase under the control of the endogenous
Ptf1-p48 promoter in a knock-in experiment.
Surprisingly, nearly all acinar, ductal, and insu-
lar cells expressed the ubiquitous reporter trans-
gene in heterozygous Ptf1-p48-cre mice,
indicating that Ptf1-p48 expression does not
commit precursors to exocrine lineages, but to
all pancreatic cell fates (Fig. 4). In homozygous
animals, the phenotype was similar to that
observed in Ptf1-p48-deficient mice (48), which
suggested that in the absence of PTF1-p48, pan-
creatic cells may revert to an intestinal epithelial
fate. In summary, this result indicates that Ptf1-
p48, as with Pdx1, is expressed in the exocrine
(acinar and ductal) and endocrine cell lineages
of the pancreas and is silenced in endocrine and
duct cells shortly after they are committed. 
CONCLUSIONS AND PROSPECTIVE
Understanding pancreatic morphogenesis
and cell differentiation has obvious clinical
implications. The potential to form pancreatic
endocrine tissue, whether from stem or differen-
tiated cells, located in ducts or elsewhere in the
pancreas (or even in extrapancreatic tissues),
should not be restricted to the period of embry-
onic development. After experimental injury,
whether surgical (e.g., partial pancreatectomy,
duct ligation.) or chemical (e.g., streptozotocin
or exendin-4 treatment), the formation of new
islets in adult rodents occurs to some extent.
Pdx1 is expressed in pancreatic ductal cells dur-
ing regeneration (65) and in early pancreatic
buds during development (45). However, we
still must determine whether differentiation of
new islets in the adult recapitulates the events
taking place during development. In this con-
text, the power and elegance of the Cre/LoxP-
based approach to track cell lineages is also
applicable to the analysis of transgenic mice
encoding Cre recombinase in different subsets
of pancreatic cell types. Thus to address these
challenging questions, the strains of mice that
have been employed to determine cell lineage
relationships during development, are now
unique tools to address the cell lineage relation-
ships during adult regeneration (neogenesis) as
well as for the inactivation of specific genes in
these same pancreatic cell lineages (“condi-
tional” KO mice).
In conclusion, the Cre/LoxP lineage tracing
approach allows a better characterization of
progenitor cells not only of the pancreas, but
also for any organ. Improvement of this funda-
mental knowledge (i.e., the understanding of
our body’s cell lineages) should, in the future,
help to devise new sources of replacement tis-
sues to treat degenerative diseases resulting
from extensive cell death. 
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